Mesenchymal stem cells from p16 null mice with overexpressed cMYC developed OS tumours [115]; p16 null mice are larger than wildtype counterparts, and developed soft-tissue sarcomas among other tumour types [116]. Here, CDKN2A is linked to neoplasm.